- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVS
Recent news which mentions NVS
CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
December 12, 2022
From InvestorPlace
Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
December 09, 2022
From Benzinga
Novartis' Rare Blood Disorder Therapy Aces Second Late-Stage Trial
December 08, 2022
Tickers
NVS
From Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
December 08, 2022
From Motley Fool
From Benzinga
Novartis' Kisqali Prolongs Progression Free Survival Benefit In Metastatic Breast Cancer Versus Chemo
December 07, 2022
Tickers
NVS
From Benzinga
Novartis prostate cancer drug trial meets primary endpoint
December 05, 2022
Tickers
NVS
From MarketWatch
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
From Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
From InvestorPlace
Novartis' Malaria Treatment Candidate To Move Forward With Phase 3 Development Next Year
November 23, 2022
Tickers
NVS
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
From Benzinga
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
November 22, 2022
From Benzinga
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
November 21, 2022
From InvestorPlace
2 Top Biotech Stocks to Buy Right Now
November 19, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
From Benzinga
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
November 14, 2022
From Benzinga
Should Income Investors Buy This High-Yielding Dividend Stock?
November 13, 2022
Tickers
NVS
From Motley Fool
2 Biotech Stocks That Could Make You Richer
November 04, 2022
From Motley Fool
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
From Benzinga
3 High-Yielding Dividend Stocks That You Can Buy and Hold Forever
October 27, 2022
From Motley Fool
Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25
October 25, 2022
From Benzinga
From Motley Fool
US Stock Futures Down; Big Tech Earnings In Focus
October 25, 2022
From Benzinga
Novartis Clocks 4% Drop In Quarterly Sales, Once Again Perks Up Sandoz Earnings Outlook
October 25, 2022
Tickers
NVS
From Benzinga
Earnings Scheduled For October 25, 2022
October 25, 2022
From Benzinga
Tickers
NVS
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.